Major histocompatibility complex class II gene transcription is tightly regulated, to ensure effective immune system activity. Inappropriate expression of these genes can result in autoimmune disease. Understanding the molecular mechanisms of MHC II transcription may allow the creation of novel immune based therapies for many human diseases. Gene-specific transcription factors assemble at MHC II promoters, to initiate transcription. Of critical importance are the heterotrimeric regulatory factors X (RFX) complex and the class II trans-activator protein (CUTA). CIITA, and one subunit of RFX known as RFXAP, both interact with a chromatin remodeling factor, brahma related gene-1 (BRG1). Whether the RFXAP-BRG1 interaction leads to chromatin remodeling appears to be dependent on cell-type. To explain this observation, it is hypothesized that the appropriate histone modifications must be present at MHC II promoters for RFXAPBRG1 to effectively remodel chromatin.
In specific aim 1, histone modifications, and the enzymes responsible for those modifications, will be characterized at MHC II promoters. The observed modifications will be correlated with the ability of RFXAP-BRG1 and CIITA-BRG1 interactions to remodel chromatin. Results will provide insight into cell-type specific regulatory mechanisms controlling MHC II transcription. In the specific aim 2, a new transcriptional regulatory protein for MHC class II genes will be characterized. A cDNA that codes for a novel protein that binds the C-terminus of CIITA was recently cloned. This zinc finger protein is called CCB1. Over-expression of CCB1 results in super-activation of MHC class I and class II genes by CIITA. It is likely that CCB1 binds DNA, and may in fact interact with the W-box of MHC promoters. Employing biochemical and genetic techniques, the manner in which CCB1 alters MHC class II transcription, and CIITA activity, will be addressed. In addition, a broader role for CCB1 in gene regulation, beyond MHC genes, will be explored.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI061386-05
Application #
7537170
Study Section
Cellular and Molecular Immunology - B (CMI)
Program Officer
Rice, Jeffrey S
Project Start
2005-04-15
Project End
2009-12-31
Budget Start
2009-01-01
Budget End
2009-12-31
Support Year
5
Fiscal Year
2009
Total Cost
$239,285
Indirect Cost
Name
University of Kansas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Aleksandrova, Anastasiia; Galkin, Oleksandr; Koneni, Rupa et al. (2010) An N- and C-terminal truncated isoform of zinc finger X-linked duplicated C protein represses MHC class II transcription. Mol Cell Biochem 337:1-7
Al-Kandari, Wafa; Koneni, Rupa; Navalgund, Vandana et al. (2007) The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription. J Mol Biol 369:1175-87
Al-Kandari, Wafa; Jambunathan, Srikarthika; Navalgund, Vandana et al. (2007) ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription. Mol Immunol 44:311-21
Jambunathan, Srikarthika; Fontes, Joseph D (2007) Sumoylation of the zinc finger protein ZXDC enhances the function of its transcriptional activation domain. Biol Chem 388:965-72